Q4 2025. Management View. Scott Plesha, CEO, stated that Pelthos made “great progress” in three key areas: ZELSUVMI’ ...
Good morning, everyone, and welcome to Pelthos Therapeutics 2025 Fourth Quarter and Fiscal Year Financial Results Conference Call. Pelthos issued a press release today announcing its financial results ...
Model selection, infrastructure sizing, vertical fine-tuning and MCP server integration. All explained without the fluff. Why Run AI on Your Own Infrastructure? Let’s be honest: over the past two ...
Pelthos Therapeutics (NYSEAMERICAN:PTHS) reported fourth-quarter and full-year 2025 results on its earnings call, highlighting rapid early demand for its lead product ZELSUVMI, two newly acquired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results